Pubblicazioni Peer reviewed articles (27) Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform Autori: Erkko Ylösmäki, Leena Ylösmäki, Manlio Fusciello, Beatriz Martins, Petra Ahokas, Hanne Cojoc, Arttu Uoti, Sara Feola, Anna Kreutzman, Tuuli Ranki, Julia Karbach, Tapani Viitala, Petri Priha, Elke Jäger, Sari Pesonen, Vincenzo Cerullo Pubblicato in: Molecular Therapy - Oncolytics, 20, 2021, Page(s) 459-469, ISSN 2372-7705 Editore: Cell Press DOI: 10.1016/j.omto.2021.02.006 Viral Molecular Mimicry Influences the Antitumor Immune Response in Murine and Human Melanoma Autori: Jacopo Chiaro, Henna H.E. Kasanen, Thomas Whalley, Cristian Capasso, Mikaela Grönholm, Sara Feola, Karita Peltonen, Firas Hamdan, Micaela Hernberg, Siru Mäkelä, Hanna Karhapää, Paul E. Brown, Beatriz Martins, Manlio Fusciello, Erkko O. Ylösmäki, Dario Greco, Anna S. Kreutzman, Satu Mustjoki, Barbara Szomolay, Vincenzo Cerullo Pubblicato in: Cancer Immunology Research, 9/8, 2021, Page(s) 981-993, ISSN 2326-6066 Editore: American Association for Cancer Research Inc. DOI: 10.1158/2326-6066.cir-20-0814 Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids Autori: Firas Hamdan, Erkko Ylösmäki, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Manlio Fusciello, Sara Feola, Beatriz Martins, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Hee Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette Leusen, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm, Vincenzo Cerullo Pubblicato in: Journal for ImmunoTherapy of Cancer, 9/8, 2021, Page(s) e003000, ISSN 2051-1426 Editore: BMJ journal DOI: 10.1136/jitc-2021-003000 Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy Autori: Karita Peltonen, Sara Feola, Husen M. Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko Ylösmäki, Sari Pesonen, Rui M. M. Branca, Janne Lehtiö, Vincenzo Cerullo Pubblicato in: Cancers, 13/14, 2021, Page(s) 3408, ISSN 2072-6694 Editore: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/cancers13143408 PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification Autori: Sara Feola, Markus Haapala, Karita Peltonen, Cristian Capasso, Beatriz Martins, Gabriella Antignani, Antonio Federico, Vilja Pietiäinen, Jacopo Chiaro, Michaela Feodoroff, Salvatore Russo, Antti Rannikko, Manlio Fusciello, Satu Koskela, Jukka Partanen, Firas Hamdan, Sari M. Tähkä, Erkko Ylösmäki, Dario Greco, Mikaela Grönholm, Tuija Kekarainen, Masoumeh Eshaghi, Olga L. Gurvich, Seppo Ylä-H Pubblicato in: ACS Nano, 2021, ISSN 1936-0851 Editore: American Chemical Society DOI: 10.1021/acsnano.1c04371 GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses Autori: Firas Hamdan, Beatriz Martins, Michaela Feodoroff, Yvonne Giannoula, Sara Feola, Manlio Fusciello, Jacopo Chiaro, Gabriella Antignani, Mikaela Grönholm, Erkko Ylösmäki, Vincenzo Cerullo Pubblicato in: Molecular Therapy - Methods & Clinical Development, 20, 2021, Page(s) 625-634, ISSN 2329-0501 Editore: Cell Press DOI: 10.1016/j.omtm.2021.01.014 Patient-Derived Organoids for Precision Cancer Immunotherapy Autori: Mikaela Grönholm, Michaela Feodoroff, Gabriella Antignani, Beatriz Martins, Firas Hamdan, Vincenzo Cerullo Pubblicato in: Cancer Research, 81/12, 2021, Page(s) 3149-3155, ISSN 0008-5472 Editore: American Association for Cancer Research DOI: 10.1158/0008-5472.can-20-4026 Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity. Autori: Hirvinen M, Capasso C, Guse K, Garofalo M, Vitale A, Ahonen M, Kuryk L, Vähä-Koskela M, Hemminki A, Fortino V, Greco D, Cerullo V. Pubblicato in: Molecular Therapy oncolytics, 23, 2016, Page(s) 3-16002, ISSN 2372-7705 Editore: Cell Press DOI: 10.1038/mto.2016.2 Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy Autori: Leena Ylösmäki, Beatrice Polini, Sara Carpi, Beatriz Martins, Elena Smertina, Sara Feola, Manlio Fusciello, Karita Peltonen, Paola Nieri, Erkko Ylösmäki, Vincenzo Cerullo Pubblicato in: PLOS ONE, 14/10, 2019, Page(s) e0224072, ISSN 1932-6203 Editore: Public Library of Science DOI: 10.1371/journal.pone.0224072 A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines Autori: Feola S, Chiaro J, Martins B, Russo S, Fusciello M, Ylösmäki E, Bonini C, Ruggiero E, Hamdan F, Feodoroff M, Antignani G, Viitala T, Pesonen S, Grönholm M, Branca RMM, Lehtiö J, Cerullo V. Pubblicato in: eLIFE, 2022 Mar 22;11, 2022, Page(s) e71156, ISSN 2050-084X Editore: eLife Sciences Publications DOI: 10.7554/elife.71156 Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment Autori: Feola S., Russo S., Ylösmäki E., Cerullo V. Pubblicato in: Pharmacology & Therapeutics, 236, 2022, Page(s) 108103, ISSN 2468-1016 Editore: Elsevier - Sciencedirect DOI: 10.1016/j.pharmthera.2021.108103 Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin Autori: Erkko Ylösmäki, Manlio Fusciello, Beatriz Martins, Sara Feola, Firas Hamdan, Jacopo Chiaro, Leena Ylösmäki, Matthew J Vaughan, Tapani Viitala, Prasad S Kulkarni, Vincenzo Cerullo Pubblicato in: Journal for ImmunoTherapy of Cancer, 9/7, 2021, Page(s) e002707, ISSN 2051-1426 Editore: BMJ Journals DOI: 10.1136/jitc-2021-002707 Oncolytic Adenovirus Loaded with L-carnosine as Novel Strategy to Enhance the Antitumor Activity Autori: Garofalo M, Iovine B, Kuryk L, Capasso C, Hirvinen M, Vitale A, Yliperttula M, Bevilacqua MA, Cerullo V. Pubblicato in: Molecular Cancer Therapeutics, 15(4), 2016, Page(s) 651-660, ISSN 1535-7163 Editore: American Association for Cancer Research DOI: 10.1158/1535-7163.mct-15-0559 Pathogens: Our Allies against Cancer? Autori: Buonaguro L, Cerullo V. Pubblicato in: Molecular Therapy, Jan 6; 29(1), 2021, Page(s) 10-12, ISSN 1525-0016 Editore: Nature Publishing Group DOI: 10.1016/j.ymthe.2020.12.005 β2-Integrin Adhesion Regulates Dendritic Cell Epigenetic and Transcriptional Landscapes to Restrict Dendritic Cell Maturation and Tumor Rejection Autori: Guenther C, Faisal I, Fusciello M, Sokolova M, Harjunpää H, Ilander M, Tallberg R, Vartiainen MK, Alon R, Gonzalez-Granado JM, Cerullo V, Fagerholm SC. Pubblicato in: Cancer Immunology Research, 9(11), 2021, Page(s) 1354-1369, ISSN 2326-6074 Editore: AACR Journals DOI: 10.1158/2326-6066.cir-21-0094 A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella Autori: Fusciello M, Ylösmäki E, Feola S, Uoti A, Martins B, Aalto K, Hamdan F, Chiaro J, Russo S, Viitala T, Cerullo V. Pubblicato in: Molecular Therapy Oncolytics, 2022 Apr 19;25, 2022, Page(s) 137-145, ISSN 2372-7705 Editore: Cell Press - Elsevier DOI: 10.1016/j.omto.2022.04.002 A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma Autori: Cristian Capasso, Aniket Magarkar, Victor Cervera-Carrascon, Manlio Fusciello, Sara Feola, Martin Muller, Mariangela Garofalo, Lukasz Kuryk, Siri Tähtinen, Lucio Pastore, Alex Bunker, Vincenzo Cerullo Pubblicato in: OncoImmunology, 6/9, 2017, Page(s) e1319028, ISSN 2162-402X Editore: Taylor & Francis DOI: 10.1080/2162402X.2017.1319028 Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses Autori: Erkko Ylösmäki, Cristina Malorzo, Cristian Capasso, Oona Honkasalo, Manlio Fusciello, Beatriz Martins, Leena Ylösmäki, Antti Louna, Sara Feola, Henrik Paavilainen, Karita Peltonen, Veijo Hukkanen, Tapani Viitala, Vincenzo Cerullo Pubblicato in: Molecular Therapy, 26/9, 2018, Page(s) 2315-2325, ISSN 1525-0016 Editore: Nature Publishing Group DOI: 10.1016/j.ymthe.2018.06.008 Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors Autori: S. Feola, C. Capasso, M. Fusciello, B. Martins, S. Tähtinen, M. Medeot, S. Carpi, F. Frascaro, E. Ylosmäki, K. Peltonen, L. Pastore, V. Cerullo Pubblicato in: OncoImmunology, 2018, Page(s) e1457596, ISSN 2162-402X Editore: Taylor & Francis DOI: 10.1080/2162402x.2018.1457596 Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma Autori: Cristian Capasso, Mari Hirvinen, Mariangela Garofalo, Dmitrii Romaniuk, Lukasz Kuryk, Teea Sarvela, Andrea Vitale, Maxim Antopolsky, Aniket Magarkar, Tapani Viitala, Teemu Suutari, Alex Bunker, Marjo Yliperttula, Arto Urtti, Vincenzo Cerullo Pubblicato in: OncoImmunology, 5/4, 2015, Page(s) e1105429, ISSN 2162-402X Editore: Taylor & Francis online DOI: 10.1080/2162402X.2015.1105429 Artificially cloaked viral nanovaccine for cancer immunotherapy Autori: Manlio Fusciello, Flavia Fontana, Siri Tähtinen, Cristian Capasso, Sara Feola, Beatriz Martins, Jacopo Chiaro, Karita Peltonen, Leena Ylösmäki, Erkko Ylösmäki, Firas Hamdan, Otto K. Kari, Joseph Ndika, Harri Alenius, Arto Urtti, Jouni T. Hirvonen, Hélder A. Santos, Vincenzo Cerullo Pubblicato in: Nature Communications, 10/1, 2019, ISSN 2041-1723 Editore: Nature Publishing Group DOI: 10.1038/s41467-019-13744-8 Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site Autori: Alessandra Lopes, Sara Feola, Sophie Ligot, Manlio Fusciello, Gaëlle Vandermeulen, Véronique Préat, Vincenzo Cerullo Pubblicato in: Journal for ImmunoTherapy of Cancer, 7/1, 2019, ISSN 2051-1426 Editore: BMC part of Spring Nature DOI: 10.1186/s40425-019-0644-7 Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor Autori: Flavia Fontana, Manlio Fusciello, Christianne Groeneveldt, Cristian Capasso, Jacopo Chiaro, Sara Feola, Zehua Liu, Ermei M. Mäkilä, Jarno J. Salonen, Jouni T. Hirvonen, Vincenzo Cerullo, Hélder A. Santos Pubblicato in: ACS Nano, 13/6, 2019, Page(s) 6477-6490, ISSN 1936-0851 Editore: American Chemical Society DOI: 10.1021/acsnano.8b09613 Exploiting pre-existing immunity to enhance oncolytic cancer immunotherapy Autori: Siri Tähtinen, Sara Feola, Cristian Capasso, Netta Laustio, Christianne Groeneveldt, Erkko O Ylösmäki, Leena Ylösmäki, Beatriz Martins, Manlio Fusciello, Marta Medeot, Maria Tagliamonte, Jacopo Chiaro, Firas Hamdan, Karita Peltonen, Tuuli Ranki, Luigi Buonaguro, Vincenzo Cerullo Pubblicato in: Cancer Research, 2020, Page(s) canres.2062.2019, ISSN 0008-5472 Editore: American Association for Cancer Research DOI: 10.1158/0008-5472.can-19-2062 Design and application of oncolytic viruses for cancer immunotherapy Autori: Erkko Ylösmäki, Vincenzo Cerullo Pubblicato in: Current Opinion in Biotechnology, 65, 2020, Page(s) 25-36, ISSN 0958-1669 Editore: Elsevier BV DOI: 10.1016/j.copbio.2019.11.016 Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma Autori: Sara Carpi, Beatrice Polini, Stefano Fogli, Adriano Podestà, Erkko Ylösmäki, Vincenzo Cerullo, Antonella Romanini, Paola Nieri Pubblicato in: Expert Review of Molecular Diagnostics, 20/1, 2020, Page(s) 19-30, ISSN 1473-7159 Editore: Future Drugs Ltd. DOI: 10.1080/14737159.2020.1696194 Peptides-Coated Oncolytic Vaccines for Cancer Personalized Medicine Autori: Feola S, Russo S, Martins B, Lopes A, Vandermeulen G, Fluhler V, De Giorgi C, Fusciello M, Pesonen S, Ylösmäki E, Antignani G, Chiaro J, Hamdan F, Feodoroff M, Grönholm M, Cerullo V. Pubblicato in: Frontiers Immunology, 14 April 2022; 13, 2022, Page(s) 826164, ISSN 1664-3224 Editore: Frontiers DOI: 10.3389/fimmu.2022.826164 Non-peer reviewed articles (1) Uncovering the Tumor Antigen Landscape: What to Know about the Discovery Process Autori: Sara Feola, Jacopo Chiaro, Beatriz Martins, Vincenzo Cerullo Pubblicato in: Cancers, 12/6, 2020, Page(s) 1660, ISSN 2072-6694 Editore: Multidisciplinary Digital Publishing Institute (MDPI) DOI: 10.3390/cancers12061660 È in corso la ricerca di dati su OpenAIRE... Si è verificato un errore durante la ricerca dei dati su OpenAIRE Nessun risultato disponibile
